|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aligos Therapeutics (NASDAQ: ALGS) through any online brokerage.
The latest price target for Aligos Therapeutics (NASDAQ: ALGS) was reported by SVB Leerink on September 9, 2021. The analyst firm set a price target for 29.00 expecting ALGS to rise to within 12 months (a possible 122.73% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $13.02 last updated Today at 3:21:08 PM.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics’s $Q3 earnings are confirmed for after-market on November 4, 2021.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.